Gorman Kevin Charles's Form 4 filing
Neurocrine Biosciences Inc (NBIX) · filed May 29, 2025
- Accession no.
- 0000914475-25-000137
- Filed
- May 29, 2025
- Trade date
- May 27, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction. Open-market sales total $1.16M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gorman Kevin CharlesCIK 0001201096 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 27, 2025 | Common Stock | SSaleDisposed | −9,613 | $120.38 | −$1,157,212.94 | 514,596 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.